Resources

Elevated 1-hour plasma glucose (1hPG) levels in persons without overt diabetes (DM) may be a marker for cardiovascular risk, according to the results of a study.  

The drug rituximab already used to treat autoimmune disorders may also slow the destruction of insulin-producing cells in patients with insulin-dependent (Type 1) diabetes.

Novo Nordiskstarted the first human tests on an experimental insulin pill, NN1952, joining companies seeking to develop an alternative to daily injections for diabetes patients who need the hormone to control their disease.  

Proton pump inhibitor therapy is associated with improved hemoglobin A1c levels in non-insulin-dependent Type 2 diabetes patients, based on results from two retrospective studies.

Injecting the corticosteroid triamcinolone into the eye may slow the progression of diabetic retinopathy, a complication of diabetes that can cause vision loss and blindness, according to a report.  

Taller patients with Type 2 diabetes are at greater risk for lower-limb amputations, according to a secondary analysis from the FIELD Study.

A 21-year old airman severely wounded in Afghanistan is recovering at Walter Reed Army Medical Center, Bethesda, MD, after several surgeries and an unprecedented transplant.

Generex Inc., announced that it has signed a long-term agreement with sanofi-aventis for the manufacture and supply of recombinant human insulin crystals for commercial and clinical trial use in Generex’s proprietary buccal insulin spray product, Generex Oral-lyn™.  

“Higher levels of physical activity, in particular activity of moderate to higher intensities, are prospectively associated with lower levels of fat mass in early adolescence. Interventions to raise levels of physical activity in children are likely to be important in the fight against obesity.”

A new study found that more than one-fifth of dialysis patients received a contraindicated antithrombotic medication when they underwent percutaneous coronary intervention (PCI), raising their risk of adverse outcomes….